Patient group input requested for a new EUnetHTA Assessment on surgical techniques and devices for the treatment of benign prostatic hyperplasia.
EUnetHTA deems patient involvement very important in the production of Joint/Collaborative Assessment reports. We recognise that patients and those who support them have unique knowledge about what it is like to live with a specific disease or medical condition. We
The role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the current pandemic – Final Project Plan now published
EUnetHTA is pleased to announce the publication of the final project plan of its Rapid Collaborative Review on the role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the current pandemic. This is the first one of a series
The summary from the EUnetHTA-EFPIA Technical Meeting, held on 2 December 2019 at the Haute Autorité de Santé in Paris, is now available for access. Please find the summary at this link and on the EFPIA site.
PTJA12 – Glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (AML) in adult patients who are not candidates for standard induction chemotherapy.
The final project plan of the relative effectiveness assessment of ‘Glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (AML) in adult patients who are not candidates for standard induction
The minutes from the EMA-EUnetHTA Bilateral Meeting, hosted by EUnetHTA at the Zorginstituut Nederland (ZIN) in Diemen, Netherlands, on 21st November, 2019, are now available for access. Topics discussed included a follow-up on registries, patient-reported outcomes as part of evidence generation
A list of Frequently Asked Questions on Declaration of Interest is now available to accompany and inform the confidentiality process. Follow the link for more information: https://eunethta.eu/doi/
We are happy to announce that our paper, 'The fourth edition of the European Network for Health Technology Assessment: highlights and outcomes', has been published this week on the International Journal of Technology Assessment in Health Care. The paper is available
Recommendations for Horizon Scanning, Topic Identification, Selection and Prioritisation for European Cooperation on Health Technology Assessment now available
The final report ‘Recommendations for Horizon Scanning, Topic Identification, Selection and Prioritisation for European Cooperation on Health Technology Assessment’ is now available. The draft recommendations were under consultation during the period July–September 2018. An overview and response to the feedback during
“Healthcare Professional Involvement in Relative Effectiveness Assessments” is now published and available for access
At the request of the EUnetHTA Executive Board, a cross-work package (WP) task group on the involvement of Health Care Providers (HCP) and Patients & Consumers (P&C) was established in Fall 2017. The task group includes representatives from WP1, WP2,
EUnetHTA Joint Action 3 has received official approval from Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) for an extension of an additional 12 months without additional funding. This prolongation is meant to allow the finalisation of outstanding deliverables and,